Psoriatic arthritis - continuing authority application form (PB106)
Use this form to apply for continuing PBS subsidised treatment with a biological agent for adult patients with psoriatic arthritis.
Biological agent refers to:
- adalimumab
- certolizumab pegol
- etanercept
- golimumab
- guselkumab
- infliximab
- ixekizumab
- secukinumab
- tofacitinib
- upadacitinib
- ustekinumab.
Download and complete the Psoriatic arthritis - continuing authority application form.
This PDF is fillable. You can fill it out on your device, or print it and complete it by hand.
You can upload this form in HPOS.
If you have a disability or impairment and use assistive technology, you may not be able to access our forms. If you can’t, please contact us. We can help you access, complete and submit them.
Page last updated: 1 October 2021
This information was printed 7 October 2021 from https://www.servicesaustralia.gov.au/organisations/health-professionals/forms/pb106. It may not include all of the relevant information on this topic. Please consider any relevant site notices at https://www.servicesaustralia.gov.au/individuals/site-notices when using this material.